四联药物治疗幽门螺杆菌感染慢性胃炎的临床价值分析

Analysis of the clinical value of quadruple drugs therapy in the treatment of chronic gastritis with Helicobacter pylori infection

目的:探讨四联药物治疗幽门螺杆菌感染慢性胃炎的临床效果。方法:2019年1-6月收治幽门螺杆菌感染慢性胃炎患者80例,随机分为两组,各40例。对照组采取三联药物治疗,研究组采取四联药物治疗。比较两组治疗效果。结果:研究组治疗总有效率、幽门螺杆菌根除率及患者满意度均明显高于对照组,差异有统计学意义(P<0.05)。结论:四联药物应用于治疗幽门螺杆菌感染慢性胃炎,可提高临床治疗效果和幽门螺杆菌根除率,提升患者满意度。

Objective:To explore the clinical effect of quadruple drugs therapy in the treatment of chronic gastritis with Helicobacter pylori infection.Methods:From January to June 2019,80 cases of chronic gastritis with Helicobacter pylori infection were enrolled,they were randomly divided into two groups with 40 cases in each group.The control group was treated with triple drugs therapy and the study group was treated with quadruple drugs therapy.The therapeutic effects between the two groups was compared.Results:The total effective rate of treatment,the eradication rate of Helicobacter pylori and the satisfaction of patients in the study group were significantly higher than in the control group,the differences were statistically significant(P<0.05).Conclusion:The application of quadruple drugs therapy in the treatment of chronic gastritis with Helicobacter pylori infection can improve the therapeutic effect and the eradication rate of Helicobacter pylori and improve the satisfaction of patients.